Sandra Saouaf | |
---|---|
Nationality | American |
Other names | Sandra Jerrold-Jones, Sandra J. Saouaf |
Alma mater |
Rutgers College University of Pennsylvania |
Occupation | immunologist |
Years active | 1995-present |
Employer(s) |
Bristol-Myers Squibb GlaxoSmithKline University of Pennsylvania Atlantic Bio Sci, LLC |
Sandra Saouaf is an American immunologist who researches autoimmune diseases, such as rheumatoid arthritis, type 1 diabetes, multiple sclerosis and others.
Sandra Jerrold-Jones obtained a BA from Rutgers College in biochemistry and went on to earn a PhD in immunology from the University of Pennsylvania. [1] After completion of her degree, Saouaf went to work in the cell signaling laboratory of Bristol-Myers Squibb [2] [3] where she completed her post doctorate fellowship. [4] She then worked briefly at GlaxoSmithKline before returning to the University of Pennsylvania. [2] Saouaf left the university and began a consulting business with pharmaceutical and biotechnical companies, [2] hoping to help speed the process of discoveries for drugs to treat autoimmune disease. In 2012, together with University of Pennsylvania colleagues, she "discovered a possible treatment approach...through oral drugs" and founded Atlantic Bio Sci, LLC. [1] In 2013, she won a Fellowship from the Alliance of Women Entrepreneurs. [5]
Sandra Saouaf | |
---|---|
Nationality | American |
Other names | Sandra Jerrold-Jones, Sandra J. Saouaf |
Alma mater |
Rutgers College University of Pennsylvania |
Occupation | immunologist |
Years active | 1995-present |
Employer(s) |
Bristol-Myers Squibb GlaxoSmithKline University of Pennsylvania Atlantic Bio Sci, LLC |
Sandra Saouaf is an American immunologist who researches autoimmune diseases, such as rheumatoid arthritis, type 1 diabetes, multiple sclerosis and others.
Sandra Jerrold-Jones obtained a BA from Rutgers College in biochemistry and went on to earn a PhD in immunology from the University of Pennsylvania. [1] After completion of her degree, Saouaf went to work in the cell signaling laboratory of Bristol-Myers Squibb [2] [3] where she completed her post doctorate fellowship. [4] She then worked briefly at GlaxoSmithKline before returning to the University of Pennsylvania. [2] Saouaf left the university and began a consulting business with pharmaceutical and biotechnical companies, [2] hoping to help speed the process of discoveries for drugs to treat autoimmune disease. In 2012, together with University of Pennsylvania colleagues, she "discovered a possible treatment approach...through oral drugs" and founded Atlantic Bio Sci, LLC. [1] In 2013, she won a Fellowship from the Alliance of Women Entrepreneurs. [5]